Publications by authors named "Amy Sing"

Claim this Profile
E
Erratum: Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
Harry D Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Amy P Sing

J Surg Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Eleftherios P Mamounas, Gong Tang, Soonmyung Paik, Frederick L Baehner, Qing Liu, Amy P Sing

Breast Cancer Res Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
Harry D Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Amy P Sing

J Surg Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
Jennifer B Manders, Henry M Kuerer, Benjamin D Smith, Cornelia McCluskey, William B Farrar, Amy P Sing

Ann Surg Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Eleftherios P Mamounas, Qing Liu, Soonmyung Paik, Frederick L Baehner, Gong Tang, Amy P Sing

J Natl Cancer Inst· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
Tari A King, Jaclyn P Lyman, Mithat Gonen, Amy Voci, Marina De Brot, Amy Pratt Sing

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.
Norman Wolmark, Eleftherios P Mamounas, Frederick L Baehner, Steven M Butler, Gong Tang, Amy P Sing

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
Anosheh Afghahi, Maya Mathur, Caroline A Thompson, Aya Mitani, Joseph Rigdon, Amy P Sing

J Oncol Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.
Sandra M Swain, Raquel Nunes, Carl Yoshizawa, Megan Rothney, Amy P Sing

Adv Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Michael D Alvarado, Che Prasad, Megan Rothney, Diana B Cherbavaz, Amy P Sing

Adv Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Denise A Yardley, Nancy W Peacock, Mythili Shastry, Howard A Burris, Rebecca G Bechhold, Amy P Sing

Breast Cancer Res Treat· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
Michael Alvarado, Dennis L Carter, J Michael Guenther, James Hagans, Rachel Y Lei, Amy P Sing

J Surg Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Thomas G Frazier, Kevin R Fox, J Stanley Smith, Christine Laronga, Anita McSwain, Amy P Sing

Pharmaceuticals (Basel)· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
Fairooz F Kabbinavar, Patrick J Flynn, Mark Kozloff, Mark A Ashby, Amy Sing

Eur J Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).
Blase N Polite, Amy Sing, Daniel J Sargent, Axel Grothey, Jordan Berlin

Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network.
Eric Nadler, Elaine Yu, Arliene Ravelo, Amy Sing, Michael Forsyth

Oncologist· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Mark F Kozloff, Jordan Berlin, Patrick J Flynn, Fairooz Kabbinavar, Mark Ashby, Amy P Sing

Oncology· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Kathy D Miller, Linnea I Chap, Frankie A Holmes, Melody A Cobleigh, P Kelly Marcom, Amy P Sing

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
James A Posey, Mohammad B Khazaeli, Michael A Bookman, Anahit Nowrouzi, William E Grizzle, Amy P Sing

Clin Cancer Res· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis